Back

9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell Carcinomas

Carbone, F.; Huang, J. K.; Perelli, L.; Del Poggetto, E.; Gutschner, T.; Tomihara, H.; Soeung, M.; Lam, T. N. A.; Xia, R.; Zhu, C.; Song, X.; Zhang, J.; Sircar, K.; Malouf, G. G.; Sgambato, A.; Karam, J. A.; Gao, J.; Jonasch, E.; Viale, A.; Draetta, G. F.; Futreal, A.; Bakouny, Z.; Van Allen, E. M.; Choueiri, T.; Msaouel, P.; Litchfield, K.; Turajlic, S.; Heffernan, T. P.; Chen, Y. B.; DiNatale, R. G.; Hakimi, A. A.; Bristow, C. A.; Tannir, N. M.; Carugo, A.; Genovese, G.

2020-11-04 cancer biology
10.1101/2020.11.03.367433 bioRxiv
Show abstract

Dedifferentiation and acquisition of chromosomal instability in renal cell carcinoma portends dismal prognosis and aggressive clinical behavior. However, the absence of reliable experimental models dramatically impacts the understanding of mechanisms underlying malignant progression. Here we established an in vivo genetic platform to rapidly generate somatic mosaic genetically engineerd immune-competent mouse models of renal tumors, recapitulating the genomic and phenotypic features of these malignancies. Leveraging somatic chromosomal engineering, we demonstrated that ablation of the murine locus syntenic to human 9p21 drives the rapid expansion of aggressive mesenchymal clones with prominent metastatic behavior, characterized by early emergence of chromosomal instability, whole-genome duplication, and conserved patterns of aneuploidy. This model of punctuated equilibrium provides a remarkable example of cross-species convergent evolution. SignificanceTo better understand the role of 9p21 in malignant progression, we generated a somatic mosaic GEMM of renal cancer, capturing the histological, genomic and evolutionary features of human disease. With this technology we demonstrated a critica role of 9p21 loss in metastatic evolution of RCC and provide a unique tool for testing new therapeutic treatments.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.